
Samsung Biologics has launched an all-cash public tender offer to acquire PolyPeptide Group in a deal valued at approximately CHF1.46bn, …
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
Ofichem acquires US drug substance CDMO Kinentia

